Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival 
Airbus CEO Warns Staff to Prepare for Rising Geopolitical Risks Amid Trade Tensions 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage 
LVMH Succession Uncertainty Raises Governance Concerns Among Shareholders 
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025 
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal 
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal 
LINCOLN, Nebraska (May 16, 2017) — National Research Corporation (NASDAQ:NRCIA and NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 (ten cents) per Class A share and $.60 (sixty cents) per Class B share payable Friday, July 14, 2017, to shareholders of record as of the close of business on Thursday, June 30, 2017.
|
|||
For more than 36 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8d47a911-1df2-42de-805c-aa9b475d5b0a
Kevin Karas NRC Health 4024722525 [email protected]
